Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Arrotex Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (4067)
Cancellation by sponsor (212)
Cancellation or suspension (28)
Prescription medicine registration (4)
Listed medicine compliance report (2)

Date

2026 (52)
2025 (139)
2024 (241)
2023 (129)
2022 (152)
2021 (83)
2020 (166)
2019 (224)
2018 (258)
2017 (305)
2016 (333)
2015 (311)
2014 (368)
2013 (281)
2012 (299)
2011 (296)
2010 (104)
2009 (76)
2008 (94)
2007 (92)
2006 (48)
2005 (34)
2004 (39)
2003 (33)
2002 (26)
2001 (25)
2000 (32)
1999 (10)
1998 (7)
1997 (5)
1996 (5)
1995 (2)
1994 (2)
1993 (1)
1992 (7)
1991 (34)

Search

Sponsor content

4313 result(s) found, displaying 721 to 730

PHENTERMINE GPPL phentermine (as hydrochloride) 40 mg modified release capsule blister pack (310859)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE GPPL phentermine (as hydrochloride) 40 mg modified release capsule blister pack.
PHENTERMINE ARW phentermine (as hydrochloride) 30 mg modified release capsule blister pack (310864)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE ARW phentermine (as hydrochloride) 30 mg modified release capsule blister pack.
PHENTERMINE GPPL phentermine (as hydrochloride) 30 mg modified release capsule blister pack (310862)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE GPPL phentermine (as hydrochloride) 30 mg modified release capsule blister pack.
PHENTODUR phentermine (as hydrochloride) 15 mg modified release capsule blister pack (310850)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTODUR phentermine (as hydrochloride) 15 mg modified release capsule blister pack.
PHENTODUR phentermine (as hydrochloride) 40 mg modified release capsule blister pack (310863)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTODUR phentermine (as hydrochloride) 40 mg modified release capsule blister pack.
PHENTODUR phentermine (as hydrochloride) 30 mg modified release capsule blister pack (310861)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTODUR phentermine (as hydrochloride) 30 mg modified release capsule blister pack.
PHENTEMINE ARW phentermine (as hydrochloride) 15 mg modified release capsule blister pack (310851)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTEMINE ARW phentermine (as hydrochloride) 15 mg modified release capsule blister pack.
PHENTERMINE GPPL phentermine (as hydrochloride) 15 mg modified release capsule blister pack (310865)

11 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHENTERMINE GPPL phentermine (as hydrochloride) 15 mg modified release capsule blister pack.
APO-LEFLUNOMIDE leflunomide 10mg tablets bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-LEFLUNOMIDE leflunomide 20mg tablets bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd

Pages

First page
Previous page
…
Page 69
Page 70
Page 71
Page 72
Current page 73
Page 74
Page 75
Page 76
Page 77
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.